Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1650 of 2051 entries
View as:

A Study of MK-8527 in Participants With Moderate and Severe Renal Impairment (MK-8527-008)

Phase: N/A Priority: Normal
NCT ID: NCT06295796 Org: User:
Start: 06/20/24 End: 01/31/25 Due: 01/31/26

Study of Pembrolizumab/Vibostolimab Coformulation (MK-7684A) in Combination With Chemotherapy Versus Pembrolizumab Plus Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (MK-7684A-007/KEYVIBE-007)

Phase: N/A Priority: Normal
NCT ID: NCT05226598 Org: User:
Start: 03/24/22 End: 01/09/26 Due: 01/09/27

Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)

Phase: N/A Priority: Normal
NCT ID: NCT03765918 Org: User:
Start: 12/17/18 End: 09/10/26 Due: 09/10/27

Efficacy and Safety of High-dose Interferon Alfa-2b (Intron A®) for the Adjuvant Treatment of Malignant Melanoma (Study P04083)

Phase: N/A Priority: Normal
NCT ID: NCT00749684 Org: User:
Start: 12/31/96 End: 09/30/09 Due: 09/30/10

A Lot-to-Lot Consistency Study to Evaluate Safety, Tolerability, and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Healthy Adults (V212-014)

Phase: N/A Priority: Normal
NCT ID: NCT02180295 Org: User:
Start: 07/31/14 End: 03/31/15 Due: 03/31/16

Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of MK-8892 in Participants With Pulmonary Arterial Hypertension (PAH) (MK-8892-005)

Phase: N/A Priority: Normal
NCT ID: NCT01926509 Org: User:
Start: 11/14/13 End: 09/08/14 Due: 09/08/15

Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)

Phase: N/A Priority: Normal
NCT ID: NCT02275780 Org: User:
Start: 12/01/14 End: 03/06/23 Due: 03/06/24

A Study to Assess the Effects of MK0822 in Prolonging Time to First Bone Metastasis in Men With Castration-Resistant Prostate Cancer (0822-030)

Phase: N/A Priority: Normal
NCT ID: NCT00691899 Org: User:
Start: 09/30/08 End: 09/30/08 Due: 09/30/09

Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019)

Phase: N/A Priority: Normal
NCT ID: NCT01953601 Org: User:
Start: 11/05/13 End: 04/17/18 Due: 04/17/19

Safety and Efficacy of Pembrolizumab Compared to Placebo in Resected High-risk Stage II Melanoma (MK-3475-716/KEYNOTE-716)

Phase: N/A Priority: Normal
NCT ID: NCT03553836 Org: User:
Start: 09/12/18 End: 10/12/33 Due: 10/12/34

A Study of Rofecoxib in the Treatment of Post-Operative Pain After Total Knee Joint Replacement (0966-259)

Phase: N/A Priority: Normal
NCT ID: NCT00140920 Org: User:
Start: 05/25/04 End: 09/27/04 Due: 09/27/05

Effects of Once and Twice Daily Dosing Regimen of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-040)

Phase: N/A Priority: Normal
NCT ID: NCT01054300 Org: User:
Start: 02/17/10 End: 04/07/10 Due: 04/07/11

Evaluation of the Immunogenicity and Safety of VARIVAX™ in Healthy Russians (V210-058)

Phase: N/A Priority: Normal
NCT ID: NCT03843632 Org: User:
Start: 03/01/19 End: 06/19/20 Due: 06/19/21

Efficacy and Safety Study of Org 50081 (Esmirtazapine) in Elderly Participants (P05709)

Phase: N/A Priority: Normal
NCT ID: NCT00561821 Org: User:
Start: 11/20/07 End: 12/21/09 Due: 12/21/10

Ridaforolimus in Treatment of Sarcoma-SUCCEED (Sarcoma Multi-Center Clinical Evaluation of the Efficacy of Ridaforolimus)(8669-011 AM6)

Phase: N/A Priority: Normal
NCT ID: NCT00538239 Org: User:
Start: 10/31/07 End: 12/31/12 Due: 12/31/13

A Study of V110 a Pneumococcal Vaccine in Healthy Adults (V110-013)

Phase: N/A Priority: Normal
NCT ID: NCT00127153 Org: User:
Start: 03/31/05 End: 05/31/05 Due: 05/31/06

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Healthy Adults 50 Years of Age or Older (V114-016/PNEU-PATH)

Phase: N/A Priority: Normal
NCT ID: NCT03480763 Org: User:
Start: 06/22/18 End: 12/23/19 Due: 12/23/20

A Single and Multiple-Dose Study of MK-8521 in Healthy and Obese Males (MK-8521-002)

Phase: N/A Priority: Normal
NCT ID: NCT02055547 Org: User:
Start: 05/10/13 End: 09/17/13 Due: 09/17/14

Treatment of Patients With Chronic Hepatitis C With PegIntron as Monotherapy or in Combination With Ribavirin (Study P04437)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00705666 Org: User:
Start: 02/28/06 End: 07/31/08 Due: 07/31/09

Efficacy and Safety of MK-8189 in Participants With an Acute Episode of Schizophrenia (MK-8189-008)

Phase: N/A Priority: Normal
NCT ID: NCT04624243 Org: User:
Start: 12/15/20 End: 06/21/24 Due: 06/21/25

A Study of Two Methodologies for Measuring Blood Flow in the Brain in Response to Non-Drug Stimuli (P08085/MK-0000-180)

Phase: N/A Priority: Normal
NCT ID: NCT01244282 Org: User:
Start: 11/30/10 End: 04/30/11 Due: 04/30/12

Dose Response Finding Study of MK-0431/ONO-5435 in Japanese Subjects With Impaired Glucose Tolerance (MK-0431-105)

Phase: N/A Priority: Normal
NCT ID: NCT01405911 Org: User:
Start: 08/16/11 End: 04/09/12 Due: 04/09/13

A Study of the Kinetics of a 13C-Cholesterol Infusate in Healthy Male Subjects (0000-108)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT01101763 Org: User:
Start: 08/31/08 End: 12/31/08 Due: 12/31/09

Comparison of Finasteride and Tamsulosin for Treatment of Benign Prostatic Hyperplasia (BPH) (MK-0906A-149 AM2)

Phase: N/A Priority: Normal
NCT ID: NCT01534351 Org: User:
Start: 08/01/13 End: 11/18/13 Due: 11/18/14

Study of Pembrolizumab (MK-3475) in Combination With Dinaciclib (MK-7965) in Hematologic Malignancies (MK-3475-155/KEYNOTE-155)

Phase: N/A Priority: Normal
NCT ID: NCT02684617 Org: User:
Start: 03/29/16 End: 04/06/20 Due: 04/06/21